|
ANAPC7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.94729999997345E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.2839000053726E-08 |
| Normal-vs-Stage2 |
7.566700E-04 |
| Normal-vs-Stage3 |
1.77170000004168E-06 |
| Normal-vs-Stage4 |
2.098800E-01 |
| Stage1-vs-Stage2 |
6.623200E-01 |
| Stage1-vs-Stage3 |
7.240000E-01 |
| Stage1-vs-Stage4 |
2.274300E-02 |
| Stage2-vs-Stage3 |
5.497800E-01 |
| Stage2-vs-Stage4 |
1.044370E-01 |
| Stage3-vs-Stage4 |
2.072300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.39089999985043E-07 |
| Normal-vs-AfricanAmerican |
4.015600E-02 |
| Normal-vs-Asian |
8.536400E-01 |
| Caucasian-vs-AfricanAmerican |
7.506200E-02 |
| Caucasian-vs-Asian |
1.318050E-01 |
| AfricanAmerican-vs-Asian |
4.693800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.50119999951104E-07 |
| Normal-vs-Female |
1.175000E-03 |
| Male-vs-Female |
9.283200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.416440E-03 |
| Normal-vs-Age(41-60Yrs) |
3.80499999996786E-06 |
| Normal-vs-Age(61-80Yrs) |
1.765940E-04 |
| Normal-vs-Age(81-100Yrs) |
4.095400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.333800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.516600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.302800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.340200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.529200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.397800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.234300E-02 |
| Normal-vs-Grade 2 |
1.79089999996496E-06 |
| Normal-vs-Grade 3 |
1.31839999994998E-06 |
| Normal-vs-Grade 4 |
2.749900E-02 |
| Grade 1-vs-Grade 2 |
8.553400E-01 |
| Grade 1-vs-Grade 3 |
7.928400E-01 |
| Grade 1-vs-Grade 4 |
8.783400E-01 |
| Grade 2-vs-Grade 3 |
8.080000E-01 |
| Grade 2-vs-Grade 4 |
5.496400E-01 |
| Grade 3-vs-Grade 4 |
4.807800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.9474999997432E-07 |
| Normal-vs-ccB subtype |
4.96650000003651E-06 |
| ccA subtype-vs-ccB subtype |
5.625000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.404860E-04 |
| Normal-vs-N1 |
7.446800E-01 |
| N0-vs-N1 |
1.381440E-01 |
|
|
